Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Diversity oriented clicking delivers β-substituted alkenyl sulfonyl fluorides as covalent human neutrophil elastase inhibitors
2022 StandoutNobel
Maintenance of Constitutive IκB Kinase Activity by Glycogen Synthase Kinase-3α/β in Pancreatic Cancer
2008
Glycogen Synthase Kinase 3 Inhibition Promotes Lysosomal Biogenesis and Autophagic Degradation of the Amyloid-β Precursor Protein
2012
Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy
2007
Synapses and Alzheimer's Disease
2012 StandoutNobel
APC and GSK-3β Are Involved in mPar3 Targeting to the Nascent Axon and Establishment of Neuronal Polarity
2004
Molecular, pharmacological and functional diversity of 5-HT receptors
2002 Standout
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
2007 Standout
Dynamic Interplay between O-Linked N-Acetylglucosaminylation and Glycogen Synthase Kinase-3-dependent Phosphorylation
2007
AKT/PKB Signaling: Navigating Downstream
2007 Standout
The role of autophagy in neurodegenerative disease
2013 Standout
Mechanisms of action of atypical antipsychotic drugs
1991
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Marine natural products
1990 Standout
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test
2004
The ground state of embryonic stem cell self-renewal
2008 StandoutNature
Amyotrophic lateral sclerosis
2011 Standout
Palladium‐Catalyzed Carbonylation Reactions of Aryl Halides and Related Compounds
2009
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Kinesin superfamily motor proteins and intracellular transport
2009 Standout
Efficacy of small‐molecule glycogen synthase kinase‐3 inhibitors in the postnatal rat model of tau hyperphosphorylation
2007
Chronic Treatment of Rats with SCH‐23390 or Raclopride Does Not Affect the Concentrations of DARPP‐32 or Its mRNA in Dopamine‐Innervated Brain Regions
1990 StandoutNobel
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
A Constant Light-Genetic Screen Identifies KISMET as a Regulator of Circadian Photoresponses
2009 StandoutNobel
Glycogen synthase kinase 3: a drug target for CNS therapies
2004
Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases
2007
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Anatomically distinct dopamine release during anticipation and experience of peak emotion to music
2011 Standout
Synthesis and Release of Dopamine in Rat Brain: Comparison Between Substantia Nigra Pars Compacta, Pars Reticulata, and Striatum
1989 StandoutNobel
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
2008 StandoutNobel
GSK3 inhibitors: development and therapeutic potential
2004
GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins
2003 Standout
Circadian Transcription Contributes to Core Period Determination in Drosophila
2008 StandoutNobel
Neurochemical brain imaging investigations of schizophrenia
1999
Drugs acting on brain dopamine receptors: A conceptual re-evaluation five years after the first selective D-1 antagonist
1989
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
Ultrasound assisted one-pot, three-components synthesis of pyrimido[1,2-a]benzimidazoles and pyrazolo[3,4-b]pyridines: A new access via phenylsulfone synthon
2011
Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics
2005
Total synthesis of (+)-scyphostatin featuring an enantioselective and highly efficient route to the side-chain via Zr-catalyzed asymmetric carboalumination of alkenes (ZACA)
2010 StandoutNobel
A review of central 5-HT receptors and their function
1999 Standout
Major Depressive Disorder
2008 Standout
AKT/PKB Signaling: Navigating the Network
2017 Standout
Tau Protein Is Required for Amyloid β-Induced Impairment of Hippocampal Long-Term Potentiation
2011
Metal-catalysed approaches to amide bond formation
2011 Standout
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
2012 Standout
Post-translational regulation of the Drosophila circadian clock requires protein phosphatase 1 (PP1)
2007
Trends in the Development of New Antidepressants. Is there a Light at the End of the Tunnel?
2004
Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis
2005
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor
2003 Standout
Recent advances in Sonogashira reactions
2011 Standout
SuFEx‐Based Polysulfonate Formation from Ethenesulfonyl Fluoride–Amine Adducts
2017 StandoutNobel
Iron Catalysis in Organic Synthesis
2015 Standout
Sulfonyl Fluorides as Alternative to Sulfonyl Chlorides in Parallel Synthesis of Aliphatic Sulfonamides
2014
Metabolic cross-talk allows labeling of O-linked β- N -acetylglucosamine-modified proteins via the N -acetylgalactosamine salvage pathway
2011 StandoutNobel
Synthesis of enantiopure (S)-7-hydroxy-3-amino-3,4-dihydro-2H-1-benzopyran en route to (+)-scyphostatin
2007
Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
2000
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degenerationin vivo
2005
Sulfonamide Synthesis via Calcium Triflimide Activation of Sulfonyl Fluorides
2018
Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3
2004
Iron-catalyzed Cross-Coupling of Electron-Deficient Heterocycles and Quinone with Organoboron Species via Innate C–H Functionalization: Application in Total Synthesis of Pyrazine Alkaloid Botryllazine A
2013
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Dopamine D2 receptors and dopamine metabolismRelationship between biochemical and behavioural effects of substituted benzamide drugs
1986
Effects of Chronic Neuroleptic Treatment on Agonist Affinity States of the Dopamine‐D2receptor in the Rat Brain
1987
THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASE
2004 Standout
Reelin Signals through Phosphatidylinositol 3-Kinase and Akt To Control Cortical Development and through mTor To Regulate Dendritic Growth
2007
Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
2011 Standout
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Antipsychotic Drugs: Importance of Dopamine Receptors for Mechanisms of Therapeutic Actions and Side Effects
2001
Fluorosulfuryl Isocyanate Enabled SuFEx Ligation of Alcohols and Amines
2021 StandoutNobel
The selectivity of protein kinase inhibitors: a further update
2007 Standout
Comparative Virtual and Experimental High-Throughput Screening for Glycogen Synthase Kinase-3β Inhibitors
2005
Nascent-Seq analysis of Drosophila cycling gene expression
2013 StandoutNobel
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Direct C−H Transformation via Iron Catalysis
2010 Standout
Dopamine Receptors: From Structure to Function
1998 Standout
Metal-Free Multicomponent Syntheses of Pyridines
2014 Standout
Works of Eva Jerning being referenced
Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418
2003
Synthesis of Novel 5-Substituted 3-Amino-3,4-dihydro-2H-1-benzopyran Derivatives and Their Interactions with the 5-HT1A Receptor
2000
Robalzotan (NAD‐299), a Novel Selective 5‐HT1AReceptor Antagonist
1999
The Pharmacological Characterization of a Novel Selective 5-Hydroxytryptamine1A Receptor Antagonist, NAD-299
1997
Effects of Remoxipride and some Related New Substituted Salicylamides on Rat Brain Receptors
1986
Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites
1996
Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer’s Disease: Design, Synthesis, and Characterization of Pyrazines
2012
In Vitro Receptor Binding Characteristics of the New Dopamine D2Antagonist [125I]NCO-298: Methodological Considerations of High Affinity Binding
1995